deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT05458453

An Exploratory Study of Esketamine in Patients After Thoracoscopic Surgery

Sponsor: The Second Affiliated Hospital of Chongqing Medical University

Conditions Esketamine Thoracoscopic Surgery
Interventions Esketamine
Updated 5 times since 2022 Last updated: Aug 15, 2023 Started: Jul 7, 2022 Primary completion: Feb 20, 2023 Completion: Feb 28, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Esketamine and Thoracoscopic Surgery, this trial is completed. The trial is conducted by The Second Affiliated Hospital of Chongqing Medical University and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2022 – ~Jun 2023 · 9 months · monthly snapshotRecruiting~Jun 2023 – ~Sep 2023 · 3 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2023 — Sep 2023 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  5. Sep 2022 — Jun 2023 [monthly]

    Recruiting PHASE4

    First recorded

Jul 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Second Affiliated Hospital of Chongqing Medical University
Data source: The Second Affiliated Hospital of Chongqing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations